{"transactions":[{"id":4461522,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":179065,"kind":"person","name":"Pfaffle Antony","position":1,"cik":"0001368953","reported_name":"Pfaffle Antony","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2017-02-08T21:01:13.000Z","date":"2017-02-07","kind":"exercise","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested as follows:  fifty percent (50%) on the date of issuance of the CE mark certification, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013."}],"balance_after":70000,"derivative":{"exercise_price":0.68,"expiration_date":"2022-12-05","underlying":"Common Stock, $0.001 par value per share","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001354488-17-000231","document":"issuerdirect_section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000135448817000231/issuerdirect_section16.xml","form_type":"4"}},{"id":4461521,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":179065,"kind":"person","name":"Pfaffle Antony","position":1,"cik":"0001368953","reported_name":"Pfaffle Antony","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-02-08T21:01:13.000Z","date":"2017-02-07","kind":"sale","acquired":false,"shares":10000,"price":2,"value":20000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001354488-17-000231","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000135448817000231/issuerdirect_section16.xml","form_type":"4"}},{"id":4461520,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":179065,"kind":"person","name":"Pfaffle Antony","position":1,"cik":"0001368953","reported_name":"Pfaffle Antony","relationship":{"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2017-02-08T21:01:13.000Z","date":"2017-02-07","kind":"exercise","acquired":true,"shares":10000,"price":0.68,"value":6800.0,"ownership":{"direct":true},"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001354488-17-000231","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000135448817000231/issuerdirect_section16.xml","form_type":"4"}},{"id":4574780,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":179065,"kind":"person","name":"Pfaffle Antony","position":1,"cik":"0001368953","reported_name":"Pfaffle Antony","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Stock Option (right to buy)","published_at":"2016-10-25T20:32:27.000Z","date":"2016-10-21","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"These options vested as follows: (a) fifty percent (50%) on the date of the issuance of the CE mark certification, which occurred on July 5th, 2013, and (b) fifty percent (50%) on December 31, 2013."}],"balance_after":80000,"derivative":{"exercise_price":0.68,"expiration_date":"2022-12-05","underlying":"Common Stock, $0.001 par value per share","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001354488-16-008420","document":"issuerdirect_section16.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000135448816008420/issuerdirect_section16.xml","form_type":"4"}},{"id":4574779,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":179065,"kind":"person","name":"Pfaffle Antony","position":1,"cik":"0001368953","reported_name":"Pfaffle Antony","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.001 par value per share","published_at":"2016-10-25T20:32:27.000Z","date":"2016-10-21","kind":"sale","acquired":false,"shares":20000,"price":2.23,"value":44600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This exercise and sale was effected pursuant to a Rule 10b5-1 trading plan executed by the reporting person on September 19, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.226 to $2.228, inclusive."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001354488-16-008420","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000135448816008420/issuerdirect_section16.xml","form_type":"4"}},{"id":4574778,"issuer":{"id":5280,"kind":"organization","name":"CorMedix Inc."},"owners":[{"id":179065,"kind":"person","name":"Pfaffle Antony","position":1,"cik":"0001368953","reported_name":"Pfaffle Antony","relationship":{"director":true,"officer":true,"officer_title":"Chief Scientific Officer"}}],"security":"Common Stock, $0.001 par value per share","published_at":"2016-10-25T20:32:27.000Z","date":"2016-10-21","kind":"exercise","acquired":true,"shares":20000,"price":0.68,"value":13600.0,"ownership":{"direct":true},"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001354488-16-008420","document":"issuerdirect_section16.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1410098/000135448816008420/issuerdirect_section16.xml","form_type":"4"}}]}